R&D
At More Reyra, we recognize that research and development (R&D) can be the decisive factor between ordinary outcomes and extraordinary success. We operate dedicated R&D units for API and Formulation Development, each of which is approved by DSIR (Department of Scientific and Industrial Research).
Research and Development (R&D) acts as a key growth driver for More Reyra Trading Company, and with a team of highly qualified scientists and advanced facilities, it has solidified its position in global markets. Our R&D efforts have strengthened our commercial product portfolio and established us as a leader in the provision and supply of specialized and complex APIs across various sectors, including oncology, immunosuppressants, antibiotics, and antifungals. Since its inception, More Reyra has successfully introduced many innovative commercial products to the market and has maintained a robust and sustainable production line. Our API R&D team primarily focuses on fermentation-based, semi-synthetic, and synthetic products that comply with European and U.S. regulatory standards and guidelines, contributing to commercial success and broad access to international markets.
More Reyra actively engages in research and development and contract supply projects with international companies, specializing in strain improvement, environment optimization, and scaling commercial products from R&D to pilot and commercial scales. This expertise, from ideation to commercialization, allows us to establish a prominent position in international markets. Our R&D efforts are supported by an advanced analytical development laboratory, which enhances the quality and precision of our commercial products. With our supply site meeting global standards, our clients benefit from the flexibility needed to pursue global project registrations. Additionally, our formulation R&D team focuses on developing specialized generic formulations in areas such as immunology, oncology, hematology, dermatology, injectables, and small-volume parenteral forms, with the aim of obtaining global approvals and introducing our commercial products to international markets.
FORMULATION
DEVELOPMENT
API
R&D CHEMICAL
API
R&D BIOTECHNOLOGY
More Reyra has established a world-class Formulation and Analytical Development Laboratory to develop and commercialize complex niche generic formulations for global markets.
More Reyra operates a state-of-the-art R&D facility certified by DSIR (Department of Science & Industrial Research), specializing in the development of advanced biotechnology products
